key: cord-1041352-q3hswyuf authors: de Silva, Thushan I.; Liu, Guihai; B Lindsey, Benjamin; Dong, Danning; Shah, Dhruv; J. Mentzer, Alexander; Angyal, Adrienn; Brown, Rebecca; D. Parker, Matthew; Ying, Zixi; Yao, Xuan; Turtle, Lance; Dunachie, Susanna; K. Maini, Mala; Ogg, Graham; Knight, Julian C.; Peng, Yanchun; Rowland-Jones, Sarah L.; Dong, Tao title: The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells date: 2021-04-08 journal: bioRxiv DOI: 10.1101/2021.04.08.438904 sha: 98f3bead5f27ad6b69722cd9cb5b373274bc52ec doc_id: 1041352 cord_uid: q3hswyuf We identify amino acid variants within dominant SARS-CoV-2 T-cell epitopes by interrogating global sequence data. Several variants within nucleocapsid and ORF3a epitopes have arisen independently in multiple lineages and result in loss of recognition by epitope-specific T-cells assessed by IFN-γ and cytotoxic killing assays. These data demonstrate the potential for T-cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T-cell as well as humoral immunity. Evolution of SARS-CoV-2 can lead to evasion from adaptive immunity generated following 50 infection and vaccination. Much focus has been on humoral immunity and spike protein mutations 51 that impair the effectiveness of neutralizing monoclonal antibodies and polyclonal sera. T-cells 52 specific to conserved proteins play a significant protective role in respiratory viral infections such 53 as influenza, particularly in broad heterosubtypic immunity 1 . T-cell responses following SARS-54 CoV-2 infection are directed against targets across the genome and may play a role in favourable 55 outcomes during acute infection and in immunosuppressed hosts with deficient B-cell immunity 2-56 4 amino acid variants were present within the 53 CD8+ T-cell epitopes with responses described 83 across multiple cohorts, with at least one variant in all epitopes ( Figure S2 , Table S3 ). 84 85 We focused on evaluating the functional impact of variants within seven immunodominant 86 epitopes (five CD8+, two CD4+) described in our study of UK convalescent donors ( Figure 1A (Figure 1E -G). In order to confirm our findings, we evaluated the 106 impact of CD8+ T-cell epitope variants on CTL killing of peptide-loaded autologous B-cells. 107 Consistent with the ELISpot data, CTL killing ability was significantly impaired by Q213K in 108 ORF3a FTSDYYQLY207-215, P13L, P13S and P13T in nucleocapsid QRNAPRITF1-17, and T362I 109 and P365S in nucleocapsid KTFPPTEPK361-369 ( Figure 1H representative sample of global sequences was obtained in two steps. First, one sequence per 262 country per epi week was selected randomly, followed by random sampling of the remaining 263 sequences to generate a sample of 4000 down-sampled sequences. The global tree was then pruned 264 using code adapted from the tree-manip package (https://github.com/josephhughes/tree-manip). 265 The tips of sequences with amino acid variants impacting T-cell recognition were colour-coded. 266 Visualisations were produced using R/ape, R/ggplot2, R/ggtree, R/treeio, R/phangorn, R/stringr, 267 R/dplyr, R/aplot. Natural T Cell-mediated Protection against Seasonal and Pandemic 310 Results of the Flu Watch Cohort Study Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-313 CoV-2 in UK convalescent individuals following COVID-19 CD8 T cells compensate for impaired humoral immunity in COVID-19 316 patients with hematologic cancer Early induction of functional SARS-CoV-2-specific T cells associates 318 with rapid viral clearance and mild disease in COVID-19 patients The first T cell response to transmitted/founder virus contributes 321 to the control of acute viremia in HIV-1 infection Antigenic drift in the influenza A virus (H3N2) nucleoprotein and 323 escape from recognition by cytotoxic T lymphocytes Long-term 325 adaptation of the influenza A virus by escaping cytotoxic T-cell recognition Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients 328 Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike 329 Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated 331 with the prominent HLA-A*02:01 phenotype SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-334 19 individuals SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic 336 Use and Target Conserved Regions of Membrane Protein SARS-CoV-2-specific T cell immunity in cases of COVID-19 and 338 SARS-CoV-2-derived peptides define heterologous and COVID-19-340 induced T cell recognition Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass 342 spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes Characterization of pre-existing and induced SARS-CoV-2-specific 345 CD8(+) T cells Asymptomatic or Mild COVID-19 SARS-CoV-2 Epitopes Are Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Shared Antigen-specific CD8+ T cell Responses Against the SARS-353 COV-2 Spike Protein Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in 355 COVID-19 patients A molecular basis for the control of preimmune escape variants by HIV-357 specific CD8+ T cells SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T 359 cell responses The emergence and ongoing convergent evolution of the N501Y 361 lineages coincides with a major global shift in the SARS-CoV-2 selective landscape Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live 364 Attenuated Influenza Virus Vaccination Competing Interests 303 304 The authors declare no competing interests 305 306 307